10-Q: Occidental Petroleum Reports Q3 2025 Earnings, Advances Debt Reduction

Occidental Petroleum reported a decline in Q3 2025 net income and EPS year-over-year, but significantly reduced long-term debt and announced the strategic sale of OxyChem to Berkshire Hathaway for $9.7 billion.

Summary

• Net income attributable to common stockholders for the nine months ended September 30, 2025, was $1,715 million, a 36% decrease from $2,674 million in the same period of 2024.
• Diluted earnings per common share (EPS) for the nine months ended September 30, 2025, decreased to $1.68 from $2.77 in the prior year period.
• Long-term debt, net, was significantly reduced to $20,846 million as of September 30, 2025, down from $24,978 million at December 31, 2024.
• Operating cash flow from continuing operations for the nine months ended September 30, 2025, was $7,898 million, a decrease from $8,183 million in the same period of 2024, primarily due to higher income tax and interest payments.
• The company announced an agreement to sell OxyChem to Berkshire Hathaway for $9.7 billion in an all-cash transaction, expected to close in the fourth quarter of 2025, with proceeds primarily allocated to debt reduction.
• Capital expenditures for the nine months ended September 30, 2025, were $5.7 billion, up from $5.2 billion in the prior year period, mainly for the oil and gas segment.
• Occidental repaid $1.0 billion of senior notes due 2025, $1.2 billion of senior notes due 2026, and $1.4 billion of a two-year term loan due 2026.
• Proceeds of approximately $890 million were received from the exercise of 41.9 million publicly traded warrants at a temporarily reduced price of $21.30 per share, used for debt repayment.
• The oil and gas segment's average daily sales volumes increased to 1,419 Mboe/d for the nine months ended September 30, 2025, from 1,282 Mboe/d in the same period of 2024, primarily due to the CrownRock Acquisition.
• The chemical segment's earnings decreased due to lower realized pricing across most product lines, particularly PVC, and higher raw material and energy costs.
• The Midstream and Marketing segment's earnings increased due to higher sulfur prices at Al Hosn and higher Waha-to-Gulf-Coast gas spreads, despite higher expenses from low-carbon ventures.
• The OBBB Act, enacted July 4, 2025, is expected to significantly reduce the company's 2025 cash tax liability through accelerated depreciation, favorable interest expense limitation, immediate R&D deduction, and increased CO2 project tax credits.
• Environmental remediation liabilities totaled $1,866 million as of September 30, 2025, with an estimated range of reasonably possible additional losses up to $1.9 billion for the 155 sites.

Sentiment

Score: 6

Explanation: While core earnings and EPS declined year-over-year due to lower commodity prices and chemical segment weakness, the company made significant progress on debt reduction through asset sales and warrant exercises, and announced a major strategic divestiture (OxyChem) that will further accelerate deleveraging. The OBBB Act is also expected to provide a favorable tax impact. The overall sentiment is cautiously positive due to strong strategic execution despite a challenging market for core earnings.

Positives

• Significant reduction in long-term debt by over $4 billion in the first nine months of 2025, improving the company's financial leverage.
• Strategic divestiture of OxyChem for $9.7 billion, with the majority of after-tax proceeds earmarked for further debt reduction, targeting below $15 billion.
• Successful exercise of publicly traded warrants generated $890 million, contributing to debt repayment.
• Increased oil and gas segment sales volumes, primarily driven by the CrownRock Acquisition, demonstrating growth in core production.
• The OBBB Act is expected to significantly reduce 2025 cash tax liability, providing a favorable tax impact.
• Net cash used by investing activities decreased substantially to $4.0 billion in 2025 from $12.8 billion in 2024, indicating reduced large-scale acquisitions and increased divestiture proceeds.

Negatives

• Net income attributable to common stockholders decreased by 36% year-over-year for the nine months ended September 30, 2025, to $1,715 million.
• Diluted EPS decreased by 39% year-over-year for the nine months ended September 30, 2025, to $1.68.
• Operating cash flow from continuing operations decreased year-over-year, primarily due to higher income tax and interest payments.
• The chemical segment experienced a decline in earnings due to lower realized prices and higher raw material and energy costs.
• Oil and gas segment earnings decreased primarily due to lower crude oil prices, despite higher sales volumes.
• The company's share of losses from equity investments, particularly Net Power, contributed to a decrease in income from equity investments and other.

Risks

• The OxyChem Transaction is subject to various risks, uncertainties, and conditions, including regulatory approvals, and may not be completed on the terms or timeline currently contemplated, if at all.
• Failure to complete the OxyChem Transaction would prevent the anticipated accelerated reduction in outstanding indebtedness, potentially adversely affecting the cost of capital and access to capital markets.
• Post-OxyChem Transaction, Occidental's business will be more exposed to fluctuations in oil, NGL, and natural gas markets, which are historically volatile.
• An Occidental subsidiary will retain environmental liabilities relating to OxyChem's legacy sites and will have post-closing indemnification obligations for pre-closing liabilities, which could be greater than expected.
• The ultimate liability at the Diamond Alkali Superfund Site (DASS) may be higher or lower than the reserved amount, with a range of reasonably possible additional losses up to $1.9 billion.
• The Tronox U.S. Tax Court litigation could result in Occidental being required to repay approximately $1.4 billion in federal and state taxes and $899 million in accrued interest if the $5.2 billion deduction is ultimately disallowed.
• General economic conditions, including slowdowns, recessions, geopolitical risks, government actions (tariffs), and inflation, can adversely impact financial performance.
• Downgrades in credit ratings could impact Occidental's ability to access capital markets and increase its cost of capital.
• Uncertainties regarding the application of the IRA's regulatory guidance and potential changes in future tax legislation could affect the ultimate impact on Occidental's businesses.
• Environmental compliance costs are expected to rise in the future, and laws may apply retroactively and regardless of fault.

Future Outlook

Occidental's financial condition and cash flows remain highly dependent on oil, NGL, and natural gas prices, as well as chemical product prices and inflationary pressures. The company aims to maintain its production base, deliver a sustainable and growing dividend, prioritize excess cash flow and divestiture proceeds for deleveraging to below $15 billion, enhance its asset base with investments in its cash-generative oil and gas business, and advance integrated technologies in CO2, power, and midstream. The OxyChem transaction is expected to close in Q4 2025, with the majority of after-tax proceeds used for debt reduction. The OBBB Act is anticipated to significantly reduce 2025 cash tax liability. The company expects current cash, operating cash flows, and RCF capacity to meet near-term obligations for the next 12 months.

Management Comments

• Occidental's management believes the accompanying unaudited Consolidated Condensed Financial Statements fairly present Occidental's results of operations and cash flows and financial position.
• Occidental's President and CEO is the chief operating decision maker (CODM) and is ultimately responsible for allocating resources and assessing the performance of each operating segment.
• Occidental's President and Chief Executive Officer and Senior Vice President and Chief Financial Officer concluded that Occidental's disclosure controls and procedures were effective as of September 30, 2025.

Industry Context

The energy sector continues to face volatility in commodity prices due to geopolitical risks, macroeconomic conditions impacting demand, and actions by OPEC and other oil-producing countries. Occidental's strategic shift to divest its chemical segment (OxyChem) and focus on its core oil and gas assets, coupled with investments in low-carbon ventures like direct air capture, aligns with broader industry trends towards energy transition while maintaining a strong fossil fuel base. The company's emphasis on deleveraging is a common theme among energy majors seeking financial resilience amidst market fluctuations. The impact of new tariff policies, as announced by President Trump in April 2025, introduces additional uncertainty for global trade and supply chains, potentially affecting costs and demand for Occidental's products.

Comparison to Industry Standards

• NA

Legal Proceedings

• Occidental is involved in lawsuits, claims, and other legal proceedings in the normal course of business, including environmental proceedings under CERCLA and similar laws.
• An Occidental subsidiary is actively pursuing resolutions with the New Mexico Environment Department regarding a proposed penalty for alleged delayed reporting of two emission events in 2020.
• The Tronox U.S. Tax Court litigation, where Anadarko is disputing an IRS disallowance of a $5.2 billion deduction, is awaiting an opinion from the Tax Court. If unsuccessful, Occidental would be required to repay approximately $1.4 billion in federal and state taxes and $899 million in accrued interest.

Related Party Transactions

• Occidental entered into a Purchase and Sale Agreement with Berkshire Hathaway Inc., a related party, for the acquisition of OxyChem for $9.7 billion.

Stakeholder Impact

• Shareholders: Potential for increased shareholder value through debt reduction and a more focused oil and gas portfolio, but also face reduced net income and EPS in the short term. Berkshire Hathaway will acquire OxyChem.
• Employees: The sale of OxyChem will impact employees within that segment, though the filing does not detail specific employment changes.
• Customers: OxyChem customers will transition to Berkshire Hathaway ownership.
• Creditors: Significant debt reduction improves creditworthiness and reduces financial risk, benefiting creditors.
• Regulatory Authorities: Ongoing engagement with EPA on environmental remediation (DASS) and IRS on tax disputes (Tronox litigation).

Next Steps

• Close the OxyChem Transaction with Berkshire Hathaway, anticipated in the fourth quarter of 2025.
• Allocate the majority of after-tax proceeds from the OxyChem sale towards debt reduction, aiming to reduce principal debt to below $15 billion.
• Continue to monitor and assess the impact of new OECD Pillar Two administrative guidance and legislation.
• Continue to perform feasibility study activities in OU3 of the Diamond Alkali Superfund Site.
• Actively pursue resolutions with the New Mexico Environment Department regarding alleged delayed reporting of emission events.
• Potentially face a put option for Zero Coupon senior notes due 2036 in October 2026, requiring a payment of $401 million if exercised.

Key Dates

Recommendation

While the year-over-year decline in net income and EPS is a negative, the strategic divestiture of OxyChem for $9.7 billion and the substantial debt reduction efforts are strong positive signals for long-term financial health and a more focused business model. The company is actively addressing its balance sheet and streamlining operations. However, the continued volatility in commodity prices, the ongoing legal and environmental liabilities, and the uncertainty surrounding the OxyChem transaction's completion and its retained liabilities warrant a 'hold' recommendation. Investors should monitor the successful closing of the OxyChem deal and the company's ability to achieve its debt reduction targets and manage its environmental and legal exposures.

Keywords

Oil and Gas, Chemicals, Midstream, Marketing, SEC Filing, 10-Q, Earnings Report, Debt Reduction, OxyChem Sale, Berkshire Hathaway, CrownRock Acquisition, Direct Air Capture, Carbon Management, Environmental Liabilities, Warrant Exercise, Commodity Prices, Energy Sector, Financial Performance, Capital Expenditures, Tax Legislation